Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Hemostasis Diagnostic Devices And Equipment Market From 2025 To 2029?
The market size of hemostasis diagnostic devices and equipment has experienced rapid expansion in the recent past. The market is projected to increase from $5.29 billion in 2024 to $6.18 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 16.8%. The substantial growth in the historic period can be credited to various factors such as clinical diagnostics, surgical procedures, monitoring of anticoagulant therapy, hemophilia, and bleeding disorders.
What Is the Projected Market Size of the Hemostasis Diagnostic Devices And Equipment Market?
The market size of hemostasis diagnostic devices and equipment is forecasted to witness a significant surge in the ensuing years, with its value anticipated to reach $10.36 billion by 2029, boasting a compound annual growth rate (CAGR) of 13.8%. The projected growth during this period can be associated with the aging demographic, prevalence of cardiovascular and chronic ailments, the rise of personalized medicine, and an increase in surgical procedures. Key upcoming trends in the forecast timeframe encompass point-of-care testing, the utilization of automation and robotics, the discovery of biomarkers, and the adoption of telemedicine and remote monitoring.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2598&type=smp
Who are the Major Competitors in the Hemostasis Diagnostic Devices And Equipment Market Outlook?
Major companies operating in the hemostasis diagnostic devices and equipment market include C. R. Bard Inc., Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, F. Hoffmann-La Roche Ltd., Grifols S.A., HemCon Medical Technologies Inc., Integra Life Sciences Corporation, Medtronic plc, Siemens AG, Thermo Fisher Scientific Inc., Trinity Biotech plc., Ethicon Inc., Boston Scientific Corporation, Olympus Corporation, Cook Group Inc., Halyard Health, Medline Industries Inc., ConMed Corporation, Moog Inc., Argon Medical Devices Inc., B. Braun Interventional Systems Inc., Bio-Rad Laboratories Inc., CareFusion Corporation, Danaher Corporation, DemeTECH Corporation, Diagnostica Stago SAS, Dolphin Sutures, EndoEvolution LLC, Haemonetics Corporation, Internacional Farmacéutica S.A. de C.V., Merit Medical Systems Inc., Quidelortho Corp, STAGO, Stryker Corporation
What Is Fueling Growth in the Hemostasis Diagnostic Devices And Equipment Market?
The rising prevalence of diseases among the elderly, which often leads to a diagnosis, is contributing to the increasing number of cardiovascular disease (CVD) surgeries conducted using hemostasis devices. As people grow older, the likelihood of illness tends to increase, leading to a spike in surgeries involving senior patients. Hemostasis devices are highly effective in accelerating the body’s natural clotting process and can monitor anticoagulation and provide guidance for transfusion therapy during surgeries. The American Heart Association states that Americans over 80 years of age are at a considerably high risk of developing CVD: approximately 83% of men and 87.1% of women are likely to suffer from some form of CVD. Hence, to enhance patient comfort and surgical success rates, the employment of hemostasis devices has become widespread.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2598&type=smp
Which Hemostasis Diagnostic Devices And Equipment Market Segments Are Growing the Fastest?
The hemostasis diagnostic devices and equipment market covered in this report is segmented –
1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments, Reagents and Kits
2) By Device Technology: Automated, Semi-Automated, Manual
3) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Other End Users
Subsegments:
1) By Analyzers: Hematology Analyzers, Platelet Function Analyzers, Thromboelastography (TEG) Analyzers
2) By Coagulation Instruments: Prothrombin Time (PT) Instruments, Activated Partial Thromboplastin Time (aPTT) Instruments, Fibrinogen Testing Instruments, Thrombin Time (TT) Instruments
3) By Other Hemostasis Instruments: Blood Clotting Time (BCT) Instruments, Bleeding Time (BT) Test Devices, Hemostatic Forceps and Clips
4) By Reagents and Kits: Coagulation Reagents, Blood Collection Kits, Point-of-care Testing Kits, Thrombosis Kits
Which Industry Trends Are Shaping the Future of the Hemostasis Diagnostic Devices And Equipment Market?
The hemostasis diagnostic device and equipment market is experiencing a surge due to the introduction of more advanced technologies. To enhance the operations’ effectiveness and quality, technological advancements like collagen vascular hemostasis devices are being put to use. Collagen, the primary structural protein in skin and other connective tissues, is widely used in its purified form for cosmetic surgeries and has now made its way into the hemostasis diagnostic devices market. Post a femoral surgery, patients often experience immobility which leads to elevated discomfort. To combat this, collagen-based closure devices are employed. As per a research undertaken by the American Journal of Neuroradiology, which examined 698 Angio-Seal closures, utilising the Angio-Seal shortened the average mobilization period by nearly 15 minutes without any significant complications. Angio seal, a form of collagen hemostasis device, reduces the average hemostasis time and enhances patient mobility.
Access The Full Report Here:
Which Countries Are Leading the Hemostasis Diagnostic Devices And Equipment Market?
North America was the largest region in the global hemostasis diagnostic devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2598
This Report Delivers Insight On:
1. How big is the hemostasis diagnostic devices and equipment market, and how is it changing globally?
2. Who are the major companies in the hemostasis diagnostic devices and equipment market, and how are they performing?
3. What are the key opportunities and risks in the hemostasis diagnostic devices and equipment market right now?
4. Which products or customer segments are growing the most in the hemostasis diagnostic devices and equipment market?
5. What factors are helping or slowing down the growth of the hemostasis diagnostic devices and equipment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model